Form 8-K - Current report:
SEC Accession No. 0001213900-24-012728
Filing Date
2024-02-13
Accepted
2024-02-12 18:03:56
Documents
16
Period of Report
2024-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193368-8k425_sensasure.htm   iXBRL 8-K 54702
2 SIDE LETTER AGREEMENT, DATED AS OF FEBRUARY 6, 2024, BY AND BETWEEN VERDE BIO HO ea193368ex10-1_sensasure.htm EX-10.1 20463
3 AMENDMENT TO THE AGREEMENT AND PLAN OF MERGER, DATED AS OF FEBRUARY 8, 2024, BY ea193368ex10-2_sensasure.htm EX-10.2 28098
  Complete submission text file 0001213900-24-012728.txt   297152

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sstc-20240206.xsd EX-101.SCH 3018
5 XBRL LABEL FILE sstc-20240206_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE sstc-20240206_pre.xml EX-101.PRE 22361
18 EXTRACTED XBRL INSTANCE DOCUMENT ea193368-8k425_sensasure_htm.xml XML 3741
Mailing Address 505 PARK AVENUE 4TH FLOOR NEW YORK NY 10022
Business Address 505 PARK AVENUE 4TH FLOOR NEW YORK NY 10022 (347) 325-4677
SensaSure Technologies, Inc. (Filer) CIK: 0001885336 (see all company filings)

EIN.: 872406468 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-41209 | Film No.: 24621749
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)